Oral administration of active vitamin D metabolites to low birthweight infants 797 pound cholecalciferol or ergocalciferol, in that they may not require in vivo hydroxylation within the liver and kidney for activation. This may be important in the preterm infant where a maturational delay in the renal enzyme la hydroxylase pathway 6 Brooke OG, Lucas A. Metabolic bone disease in preterm infants. Arch Dis Child 1985 ;60:682-5.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.